On the basis that cancer stem / early progenitor cells (CSCs) have been associated with mesenchymal characteristics we wished to test the hypothesis that TRAIL might preferentially target bCSCs within all breast cancer subtypes, including otherwise resistant epithelial-like cell lines. The gene discussed is TNFSF10; the disease is breast carcinoma.